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INTRODUCTION
The advent of accurate, automated, low-
cost sphygmomanometers has enabled 
blood pressure (BP) measurement to 
move beyond its traditional setting of the 
clinician’s office.1 This relocation improves 
accessibility, enabling more readings to be 
taken in environments less likely to induce 
white-coat hypertension or its counterpart, 
masked hypertension.2 Such out-of-office 
measurements — for example, patient 
self-monitoring (SMBP) in the home or 
ambulatory monitoring (ABPM) — have been 
demonstrated to provide more accurate 
estimates of BP that, in turn, better predict 
long-term outcomes, including mortality, 
than those taken by clinicians during 
healthcare consultations.3,4
UK and European clinical guidelines 
recommend SMBP or ABPM to confirm 
a hypertension diagnosis.5,6 For example, 
the National Institute for Health and Care 
Excellence (NICE) states that, if a clinic 
BP is ≥140/90 mmHg, ABPM should be 
offered, with SMBP as an alternative if it 
is not available or not tolerated. Although 
few studies have investigated the use of 
SMBP for hypertension diagnosis,7,8 limited 
evidence suggests it is more acceptable to 
patients than ABPM.9,10
A relatively recent out-of-office 
measurement modality is the solid-cuff 
BP monitors found in North American 
pharmacies and, increasingly, in UK 
general practice waiting rooms.11,12 They 
are designed for unsupervised patient 
use. Unlike ABPM or SMBP, there is a 
paucity of studies comparing waiting 
room-measured BP to that taken in the 
clinician’s office, or to prognostic outcomes.13 
However, these waiting room devices appear 
acceptable to patients14 and appealing to 
healthcare professionals, who can ensure 
their calibration and utilise them to achieve 
BP measurement performance targets.15 
Waiting room BP monitors could have a role 
in hypertension diagnosis, offering an out-of-
office measurement in a relatively controlled 
environment.
Much of the existing qualitative literature 
on out-of-office BP monitoring focuses on 
the experience of patients confirmed to 
have hypertension and self-monitoring in 
the home.16 Despite being recommended by 
clinical guidelines, little is known about how 
patients use and view different types of out-of-
office monitoring during diagnosis. Therefore 
this study sought to investigate how patients 
recently diagnosed with hypertension had 
used out-of-office monitoring, particularly 
the interplay between home monitoring and 
waiting room equipment. 
Research
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METHOD
Out-of-office measurement modalities 
considered 
This study focused on the use of SMBP 
and waiting room monitors, as patients, 
who control when to measure, can see the 
result and decide whether to share it with 
their clinician. Conversely, as healthcare 
professionals act as gatekeepers to 
ABPM with GPs referring patients to have 
an ambulatory monitor fitted (often by a 
nursing colleague), patients cannot access 
ABPM results themselves and are reliant 
on healthcare professionals to interpret and 
explain the results.
Study sites
Participants were recruited from the 
two practices participating in a BP self-
screening feasibility study, selected 
because of their differing characteristics. 
Practice A was in a wealthy suburban 
village with a list size of about 5000 patients. 
Practice B served a population three times 
larger in an ethnically diverse town. The 
study involved placing a solid-cuff BP 
measurement station in the waiting room 
that could transfer screening data into 
the patient’s electronic medical records. It 
aimed to assess the feasibility of a larger 
trial evaluating the system’s impact on 
hypertension detection. Apart from placing 
the monitor in the waiting room, the study 
made no intervention in patient care. A 
full description is published elsewhere 
(S Fleming & AC Tompson, unpublished 
data, 2018).
Participant recruitment
Potential interviewees, identified as recent, 
adult (aged >18 years) additions to the 
practice electronic hypertension register via 
a computer search conducted by practice 
staff, were sent a study information pack. 
In Practice A, all patients added to the 
register in the past 12 months were written 
to. In Practice B, this was extended to 
48 months due to a limited response to the 
initial mail-out. In total, 224 patients from 
across practices A and B were invited. New 
diagnoses were sought to facilitate recall of 
diagnosis and monitoring around this time.
The reply slip contained a brief 
demographic questionnaire. Replies were 
monitored to ensure that patients with a 
range of self-reported age and sex were 
interviewed. Recruitment continued until 
data saturation was reached.17
Data collection
The interviews were conducted by an 
experienced, non-clinical researcher in 
patient homes or by telephone if it was 
not possible to meet. Informed consent 
was obtained prior to all interviews. 
Participants were offered a £20 gift voucher 
to acknowledge their help.
Analysis
Interviews were semi-structured based 
on a topic guide informed by the study 
aims, which was refined based on issues 
raised in previous interviews (Box 1). 
Interviews were recorded, transcribed 
verbatim, and checked. Initial transcripts 
were thematically coded by two researchers 
and a coding frame developed that was 
applied to subsequent transcripts using the 
How this fits in 
Guidelines advocate out-of-office blood 
pressure measurement to confirm 
hypertension. This study explored patient 
experience of such monitoring, particularly 
at home and in the waiting room, during 
hypertension diagnosis. The findings will 
help general practices optimise their 
support of patients undertaking out-of-
office monitoring.
Box 1. Interview topic guide
Experiences of diagnosis
• Can you tell me how you came to be diagnosed with high blood pressure? 
• Can you remember what the result was? What did it mean to you? How did you feel? 
• What did you do next? 
• Perceptions of personal susceptibility to/causes of hypertension. 
• Perceptions of severity of hypertension.
Healthcare professional blood pressure test/home monitoring/ambulatory blood pressure monitoring/
waiting room monitor
• Who initiated this? 
• How would you describe your feelings about having this test done? 
• Can you remember what the result was? What did it mean to you?
Following diagnosis
• How would you rate your health before and after diagnosis? 
• Do you think about your blood pressure much? 
• Views about information and advice from health professionals/other sources. 
• Views about taking antihypertensive medication. 
• Was there anything you did differently after the tests? What were the reasons for this? 
• Can you talk me through the lifestyle changes that you have made (diet/exercise/smoking)?
Process of diagnosis
• What were the good (bad) aspects? 
• What did you think about the speed of the process? 
• What changes (if any) would you make?
Monitoring
• Use of the waiting room monitor. 
• Future home monitoring?
Closing the interview
•  Is there anything else you would like to say about your experience of being diagnosed with high blood 
pressure?
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constant comparison technique.18 Earlier 
interviews were re-examined for codes that 
emerged later in the dataset. NVivo (version 
11) was used to organise the transcripts 
and record the coding process. From the 
coding framework, themes were developed 
using the one sheet of paper technique,19 
then discussed by the research team and 
refined.
Socioeconomic status was assessed 
for interviewees based on their home 
postcode using the 2015 Index of Multiple 
Deprivation.20
RESULTS
Between January and May 2017, 29 
interviews were conducted from the 34 
responses received. Four responders 
were not interviewed based on their 
demographic similarity to previous recruits. 
One responder was unable to give informed 
consent due to dementia and therefore 
excluded. Interviews lasted around 
30 minutes (17–43 minutes) and were 
conducted on a one-to-one basis apart 
from when the interviewee’s partner (IDs 
18, 19, 21, 31) or grandchild (ID23) were 
present. Five out of 29 interviews were 
conducted over the telephone.
Table 1 describes the interviewee 
demographics. Using the practice register 
to identify patients newly diagnosed with 
hypertension had several limitations: first, if 
a patient changed GP practice (IDs 2, 18, 23) 
they appeared as a recent addition although 
diagnosed for some time. For others (IDs 
20, 21), based on their narratives of a long 
history of high BP, it was unclear why 
they had been identified, perhaps reflecting 
the dichotomous diagnostic threshold. The 
remainder of interviewees recalled that they 
had been diagnosed within the last 2 years 
(Table 2). Two interviewees felt they did not 
have hypertension: ID12 described themself 
as borderline whereas ID31 disagreed with 
the use of a standardised threshold.
The majority of the sample had 
undertaken out-of-office measurement, 
with around one-third (9 of 29) having 
used a waiting room BP monitor (further 
information available from the authors on 
request). Most out-of-office monitoring 
occurred either during or following initial 
identification of raised BP, particularly at 
practice B. One interviewee (ID22), however, 
had their initial elevated reading detected 
on the waiting room monitor.
The themes arising from the interviews 
were organised under four headings: 
information to empower, making the 
invisible visible, time after time, and (lack of) 
support in ‘real-life’ primary care. These are 
described below with illustrative quotes (M 
= male, F = female, SMBP = regarding BP 
self-monitoring at home, WRM = regarding 
BP measurement in the waiting room). 
Table 2. Participant-reported hypertension characteristics
  Practice A Practice B Total 
  (n = 13) (n = 16) (n = 29)
Approximate time since hypertension diagnosis, years
<1 11 6 17
1–2 1 4 5
2–3  0 2 2
>3 1 4 5
Currently taking antihypertensive treatment
No – not prescribed 1 1 2
Yes 11 10 21
Yes – has previously taken drug holidays 0 3 3
Stopped 1 2 3
Out-of-office BP monitoring experience (current or historic)
Home monitoring 11 3b 14
Waiting room monitor 1 5b 6
Ambulatory BP monitora 1 3b 4
aThree participants (Practice A: 1, Practice B: 2) did not spontaneously mention ambulatory blood pressure 
monitoring and were not asked about it. bNot all participants undertook out-of-office monitoring. BP = blood 
pressure.
Table 1. Participant-reported demographic characteristics
  Practice A Practice B Total 
  (n = 13) (n = 16) (n = 29)
Age, years
<40 0 2 2
40–49 0 2 2
50–59 2 4 6
60–69 5 3 8
70–79 4 4 8
>79 2 1 3
Sex
Male 7 7 14
Female 6 9 15
Quintile of Index of Multiple Deprivation
1 (least deprived) 11 3 14
2  1 5 6
3  1 3 4
4  0 3 3
5 (most deprived) 0 2 2
Ethnicity
White 13 12 25
African Caribbean 0 3 3
South Asian 0 1 1
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Information to empower
Out-of-office monitoring illustrated 
interviewees’ concerns or requests to their 
GPs at various points. The few who had 
used it prior to diagnosis did so in response 
to symptoms or worries about borderline 
results. One interviewee used both SMBP 
and the waiting room monitor to challenge 
her GP’s interpretation of her ABPM results 
as not requiring action:
‘They’ve got this thing where you can print 
off, so I used to go in with that whenever I 
had an appointment, “this is it”.’ (ID07, F, 
52 years, SMBP, WRM)
Out-of-office monitoring results were 
more frequently used in conversations 
during diagnosis or once diagnosed, for 
example, regarding the need for medication: 
‘I see it [self-monitoring] as a way of 
trying to convince the GP to take me off 
it [antihypertensive medication].’ (ID26, M, 
30 years, SMBP)
Healthcare professionals were perceived 
as sometimes reluctant to accept SMBP 
results taken on an unknown, unseen 
monitor:
‘I don’t think they trust you … you could write 
anything down.’ (ID24, F, 31 years, SMBP)
The waiting room monitor hosted by 
the GP practice provided a printed slip, 
improving the perceived trustworthiness of 
their reports: 
‘He [the GP] said “oh right, those are, that’s 
useful, I’ll enter that one” … they’re dated 
and timed.’ (ID30, M, 56 years, WRM)
Out-of-office monitoring also provided 
information for the interviewees. SMBP, rather 
than the waiting room monitor, was used for 
reassurance partly due to its proximity: 
‘We decided let’s have one [to be] on the 
safe side of it, you know, instead of thinking, 
“Oh I’ve got to get to the doctors and have 
one done”.’ (ID17, F, 62 years, SMBP)
Two interviewees with white-coat 
hypertension reported how self-monitoring 
helped them feel in control:
‘I don’t ever think, “oh it’s going to be high, 
and that there’ll be a problem”, I just think, 
“yeah, I’m doing this, you know, just to 
check that everything’s okay”.’ (ID24, F, 
31 years, SMBP)
Interviewees’ opinions differed regarding 
whether BP measurement in the waiting 
room was like being in the consultation 
room or at home in terms of feeling anxious.
Record keeping was linked to the rationale 
for monitoring: when for immediate 
reassurance at home no records were 
kept. Users of the waiting room monitor 
were instructed to hand their results to 
the receptionist or healthcare professional. 
No provision was made to encourage their 
own interpretation or record keeping, both 
recognised components of self-monitoring 
schemes.21
For the minority who had not undertaken 
any out-of-office monitoring, one reason 
given was the disempowering effect of being 
unable to interpret the results and use them 
as evidence: 
‘What would it tell me if I don’t know the 
numbers?’ (ID31, M, 58 years)
Making the invisible visible
The detection of elevated BP and being 
prescribed medication dominated 
narratives. Out-of-office monitoring 
provided a window onto a symptomless 
condition that was typically found 
opportunistically and without clear cause. 
Following the initial shock of detection, out-
of-office monitoring was utilised by patients 
and their GPs to understand the magnitude 
of the elevation and confirm the need for 
medication:
‘I knew I had a problem and I knew I needed 
it to be fixed.’ (ID06, M, 63 years, SMBP) 
There were usually several visits to the 
GP surgery during diagnosis, providing 
opportunities for waiting room and/or 
clinician BP measurement with SMBP 
nested among these. The waiting room 
monitor enabled out-of-office data to be 
collected during diagnosis without patients 
having to invest, either financially in a 
monitor or emotionally in a potential ‘false 
alarm’. 
A typical response to beginning 
antihypertensive treatment was that it was 
a ‘necessary evil’ with reluctance framed 
around its undefined duration and failure 
to address the underlying causes. SMBP 
could help manage this transition, providing 
data for confirmation of dose adjustments 
and reinforcing medication adherence. 
One interviewee described his response to 
getting a ‘good’ result:
‘Well that’s where it should be, keep taking 
the tablets!’ (ID09, M, 71 years, SMBP)
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Some interviewees collected out-of-
office measurements to demonstrate how 
their BP had fallen and that medication was 
unneeded: 
‘I’d been taking them sort of three times 
a day just to, so that he [the GP] could see 
what it was looking like and I said, “You 
know, can I start to come off them yet?”.’ 
(ID28, F, 46 years, SMBP)
A few used self-monitoring to inform 
drug holidays when they stopped some or 
all of their medication: 
‘If I feel better suddenly I’m, I used to, say, 
stop medicine even for 4 or 5 days and then 
check it … suddenly it’ll come up, then I 
start.’ (ID23, F, 73 years, SMBP)
Unlike office or waiting room, measuring 
at home was not under the gaze of the GP 
or practice staff, and this separation made 
it easier for some to take their own initiative. 
However, most interviewees felt that they 
required their healthcare professionals to 
interpret their results and make these sorts of 
changes. Self-monitoring was used to explore 
and attribute the causes of varying BP levels:
‘At different times of the day it fluctuated 
and some of that is due to sort of inactivity, 
activity, stress, how you’re feeling and it 
just made me think actually this isn’t just a 
constant.’ (ID28, F, 46 years, SMBP)
A minority of interviewees used diagnosis 
as a prompt to lead healthier lifestyles and 
SMBP enabled evaluation of the impact of 
these changes:
‘I realise any time I take the tablets and I do 
my exercise … I cut down my beef, stuffs like 
that … it comes down.’ (ID16, M, 50 years, 
SMBP, WRM) 
For those who embarked on changes 
coinciding with medication initiation, there 
was uncertainty regarding what had caused 
their BP to fall:
‘I must admit I wanted one day just, not to 
take them [antihypertensive medication] for 
a week to see how I would feel again and 
then monitor this and just see if it still goes 
high, or not because I don’t know if that is 
what’s keeping it down.’ (ID17, F, 62 years, 
SMBP, WRM) 
Self-monitoring, rather than the waiting 
room monitor, was used to make the 
invisible visible. At home, measurements 
taken in the context of everyday life 
facilitated patient self-management via 
lifestyle ‘choices’ and decisions regarding 
medication (non-) adherence. Such 
monitoring allowed a more intensive and/
or responsive schedule to investigate BP 
level fluctuations. The waiting room monitor 
enabled those experiencing uncertainty 
about their equipment or technique to 
double-check fluctuating readings. For 
those with no previous long-term conditions 
or ill health, the GP surgery was not (yet) a 
place that featured in their everyday routine.
Time after time
NICE guidelines recommend self-
monitoring twice daily — morning and 
evening — when diagnosing hypertension.6 
This was unfeasible if using the waiting 
room monitor. The NICE schedule was 
rarely adopted by interviewees undertaking 
SMBP either. Instead the timings were 
varied: 
‘I think the GP suggested that it would be 
better to take it at different times of the day 
… to see if there’s any correlation with how 
one’s dashing about.’ (ID04, F, 74 years, 
SMBP) 
Following diagnosis, a reduction of out-of-
office monitoring was often described, partly 
due to easing anxiety or unsustainability:
‘I feel that it has come down … so now I’m 
relaxed I’m not really taking it.’ (ID07, F, 
52 years, WRM) 
Others lost interest: 
‘We started off checking it about once a 
week, then we got bored with that and 
started checking it about once every 
3 months.’ (ID18, F, 72 years, SMBP) 
Schedules were shaped for some by their 
symptoms, the absence of which meant 
measurement was not triggered:
‘I’ve not done it for ages, actually, because 
I’ve been feeling so much better.’ (ID22, M, 
63 years, SMBP, WRM) 
For those who recorded their results 
on phone apps, lengthening intervals in 
between measurements posed challenges 
in terms of remembering passwords. 
Some developed a routine, linking self-
monitoring at home with medication taking 
and/or record keeping. Others favoured a 
more relaxed approach to avoid it becoming 
a chore: 
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‘I do it more on a natural [basis], so that 
way I feel like I’m looking after myself 
rather than I’m monitoring myself.’ (ID26, 
M, 30 years, SMBP)
The use of the waiting room monitor was 
shaped by other activities:
‘I just use it when I’ve gone up to drop a 
prescription request in.’ (ID30, M, 56 years, 
WRM) 
One interviewee preferred monitoring in 
the waiting room rather than at home: 
‘I just don’t want to be too aware of doing it.’ 
(ID13, F, 80 years, WRM) 
Linked to lobbying healthcare 
professionals, sporadic bursts of out-
of-office monitoring were sometimes 
undertaken prior to consultations, with 
the waiting room monitor being used on 
the way into their appointment to back up 
their evidence collected at home. Following 
diagnosis and dose titration, GP contact 
usually decreased:
‘I haven’t done it [self-monitored] lately … I 
think that’s probably because I haven’t had 
an appointment with the doctor. And I did 
drop out of the habit.’ (ID28, F, 46 years, 
SMBP)
In addition to fewer opportunities 
for encouragement, fewer healthcare 
consultations also meant fewer reasons to 
be in the waiting room and use the monitor 
there.
(Lack of) support in ‘real-life’ primary 
care
Interviewees highlighted the challenges 
of supporting out-of-office monitoring in 
primary care. Those with multiple conditions 
described the difficulties of adding to already 
full consultation agendas, whereas those 
reluctant to take their medication used 
the limited accessibility of the GP to avoid 
disclosure of ‘non-compliant’ behaviour. In 
some cases, following diagnosis, waning 
GP interest and support interpreting the 
results was reported: 
‘All I’m doing is taking my blood pressure 
readings and putting them on a piece of 
paper, that’s not really doing much, is it?’ 
(ID08, M, 62 years, SMBP)
Waiting room monitor users were 
reassured by the proximity of receptionists 
and because the cuff did not require 
fitting. Few interviewees had received 
SMBP instruction, instead relying on their 
monitor’s manual and/or information from 
the internet. Sometimes interviewees 
developed their own frameworks for 
interpretation, guided by their BP at 
detection: 
‘The last one I did about 154 … so that was 
really low.’ (ID17, F, 62 years, SMBP, WRM)
‘Up to 120’s good, up to 140 is pretty high.’ 
(ID22, M, 63 years, SMBP)
Some described their results using the 
interpretation tables’ colours, whereas 
others reported a single figure. Patient 
interpretation of BP measured in the 
waiting room was not encouraged by the 
GP practices.
The difficulty of checking the accuracy of 
home monitors was raised: 
‘The GPs are so busy that I don’t really 
want to take up their time doing that sort of 
thing.’ (ID09, M, 71 years, SMBP)
One GP suggested using the waiting 
room monitor as a calibration device. 
Other interviewees were reassured that 
their home and office readings were 
alike. Once diagnosed, the minority of 
interviewees chose to use the waiting room 
monitor over home monitoring, rating its 
perceived superior accuracy over reduced 
convenience: 
‘You can get one [home monitor] which is 
really cheap but it’s not calibrated to the 
right standard so it’s not much point really.’ 
(ID30, M, 56 years, WRM)
DISCUSSION
Summary
Home monitoring and waiting room 
measurement were undertaken at different 
points during hypertension diagnosis. 
The purpose of monitoring, the intended 
audience, and the schedules varied between 
individuals and over time. Out-of-office 
measurements supported patients as they 
came to terms with or, on occasion, rejected 
the need for treatment. 
Waiting room monitoring played several 
roles: it offered the potential for opportunistic 
detection of elevated BP, although few 
had used it this way. It enabled further 
measurements following an initial raised 
reading, on their own or their GP’s initiative, 
without additional appointments or having 
to invest in a BP monitor. In this way it 
mimicked extra office measurements — 
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one-off measurements — with the dated and 
timed results slips for GPs. More frequent 
measurement was possible than clinic 
monitoring but still within a medical context. 
Reduced access compared with SMBP 
was cited as a benefit by a few who feared 
overmeasurement. For those concerned by 
their ability to measure their BP accurately, 
the fixed cuff and perceived accuracy of the 
waiting room monitor were reassuring, as 
was the availability of someone to interpret 
the reading.
It was more feasible to follow the NICE 
protocol6 for hypertension diagnosis using 
SMBP, although there was limited evidence 
of its use among the interviewees. Instead, 
SMBP offered the facility for patients to 
acquaint themselves with their BP following 
initial detection of possible hypertension. 
It allowed measurement at multiple and 
differing times of day, echoing the rationale 
behind ABPM, albeit in a more flexible 
and comfortable manner. They were able 
to check in response to symptoms and, 
by measuring at home, could have record 
keeping and interpretation materials on 
hand. However, despite this, some patients’ 
own interpretations of their BP results could 
diverge from current guidelines’ orthodoxy.6
Strengths and limitations
To the authors’ knowledge, this is the first 
study to consider the patient perspective of 
out-of-office monitoring during hypertension 
diagnosis outside of trial conditions, 
including the use of waiting room monitors. 
It provides new insights, which may facilitate 
implementation of self-monitoring, with 
evidence that the use of waiting room 
monitors may increase the numbers of 
patients — and GPs — willing to accept BP 
monitoring conducted outside of the office.
Recruitment into the study was hampered 
by a low response rate and among this 
sample there was limited use of the waiting 
room monitor, also seen in the main 
pilot study (S Fleming and AC Tompson, 
unpublished data, 2018). Furthermore, 
interviewee narratives were not verified by 
medical record review. However, the focus 
of this study was patient perspectives and 
experiences, which were collected.
It was hoped to interview recently 
diagnosed patients. This was not always 
possible due to the limitations of the practice 
hypertension register and response rate at 
Practice B. Therefore, it is not possible to rule 
out recall bias, although most interviewees 
were diagnosed <2 years ago. Furthermore, 
patients were only recruited from two 
general practices, with Practice A located in 
a very affluent area. It is possible that the out-
of-office monitoring support in this sample 
may be atypical. However, a 2015 survey of a 
nationally representative sample of UK GPs 
found that 58% were using self-monitoring 
to diagnose hypertension with a range of 
thresholds and protocols being used.22
Comparison with existing literature
Discontinuation rates for antihypertensive 
medication are known to be high23 and one 
of the drivers for out-of-office monitoring 
among this sample was to demonstrate that 
antihypertensive treatment was not needed, 
although usually GP advice to the contrary 
was followed. A minority of interviewees 
used out-of-office monitoring to inform 
drug holidays, a finding that the authors 
are unaware of elsewhere in the literature. 
Conversely, a reinforcing effect of monitoring 
on medication adherence was also observed. 
A meta-analysis of trial data found that, 
among participants who were typically 
continuing with — rather than commencing 
— hypertension treatment, SMBP was 
associated with a small but significant 
increase in medication adherence.24 
In this study, out-of-office monitoring 
schedules varied over time. An easing of the 
intensity of patient-directed SMBP has been 
observed elsewhere.25 A qualitative study 
found that clinicians supported differing 
schedules for the purposes of diagnosis 
and ongoing management of hypertension, 
although the views of patient participants for 
this theme were not reported.26 
Solid-cuff monitors, either in waiting 
rooms or in pharmacies — as seen in North 
America — may have a role in hypertension 
diagnosis. However, further work is needed 
to evaluate their comparability with other 
measurement modalities. A short report13 
found that systolic waiting room BP (mean 
145.4 mmHg, standard deviation [SD] 
21.3) was significantly higher than home 
measurements (mean 131.7 mmHg, SD 9.9, 
P<0.01) but not office measurements (mean 
145.4 mmHg, SD 19.4), whereas diastolic 
waiting room BP (mean 69.2 mmHg, SD 
10.7) was significantly lower than both home 
BP (mean 73.8 mmHg, SD 8.2, P<0.01) 
and office BP (mean 74.4 mmHg, SD 11.2, 
P<0.01). However, the study inclusion 
criteria and sampling strategy were not 
reported, hampering assessment of the 
generalisability and reliability of these 
findings.
This study reiterates the difficulties of 
supporting patients undertaking out-of-
office monitoring in routine primary care.25 
A recent meta-analysis and individual 
patient data analysis concluded that self-
monitoring alone was not associated with 
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lower BP.27 However, when combined with 
co-interventions such as patient education 
or lifestyle counselling, it resulted in clinically 
significant reductions. These findings 
suggest that the patchy support received 
by patients to undertake out-of-office 
monitoring may need to be strengthened 
and allowance made for temporal changes 
in motivation and rationale to encourage 
the maintenance of this behaviour and 
maximise any benefits.
Implications for practice
SMBP and practice waiting room 
measurements have overlapping but 
differing roles for patients newly diagnosed 
with hypertension. Waiting room BP 
monitors may be a useful out-of-office 
measurement modality for patients 
unwilling and/or unable to monitor their BP 
at home during diagnosis or as they come to 
terms with the need for medication.
Measurements taken at home may be 
more effective in supporting lifestyle changes 
and medication adherence. Clinicians should 
be aware that a minority of patients may use 
self-monitored BP to inform drug holidays.
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